187 related articles for article (PubMed ID: 19123922)
21. Heme oxygenase-1 and NADPH cytochrome P450 reductase expression in experimental allergic encephalomyelitis: an expanded view of the stress response.
Emerson MR; LeVine SM
J Neurochem; 2000 Dec; 75(6):2555-62. PubMed ID: 11080209
[TBL] [Abstract][Full Text] [Related]
22. Engineering of proteolytically stable NADPH-cytochrome P450 reductase.
Bonina TA; Gilep AA; Estabrook RW; Usanov SA
Biochemistry (Mosc); 2005 Mar; 70(3):357-65. PubMed ID: 15823091
[TBL] [Abstract][Full Text] [Related]
23. Cadmium-mediated inhibition of testicular heme oxygenase activity: the role of NADPH-cytochrome c (P-450) reductase.
Trakshel GM; Kutty RK; Maines MD
Arch Biochem Biophys; 1986 Nov; 251(1):175-87. PubMed ID: 3098174
[TBL] [Abstract][Full Text] [Related]
24. Purification and characterization of a soluble form of rat liver NADPH-cytochrome P-450 reductase highly expressed in Escherichia coli.
Hayashi S; Omata Y; Sakamoto H; Hara T; Noguchi M
Protein Expr Purif; 2003 May; 29(1):1-7. PubMed ID: 12729719
[TBL] [Abstract][Full Text] [Related]
25. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase.
Gu J; Weng Y; Zhang QY; Cui H; Behr M; Wu L; Yang W; Zhang L; Ding X
J Biol Chem; 2003 Jul; 278(28):25895-901. PubMed ID: 12697746
[TBL] [Abstract][Full Text] [Related]
26. Oligomerization is crucial for the stability and function of heme oxygenase-1 in the endoplasmic reticulum.
Hwang HW; Lee JR; Chou KY; Suen CS; Hwang MJ; Chen C; Shieh RC; Chau LY
J Biol Chem; 2009 Aug; 284(34):22672-9. PubMed ID: 19556236
[TBL] [Abstract][Full Text] [Related]
27. Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity.
Kim YS; Zhuang H; Koehler RC; Doré S
Free Radic Biol Med; 2005 Jan; 38(1):85-92. PubMed ID: 15589375
[TBL] [Abstract][Full Text] [Related]
28. Interactions between cytochromes P450 2B4 (CYP2B4) and 1A2 (CYP1A2) lead to alterations in toluene disposition and P450 uncoupling.
Reed JR; Cawley GF; Backes WL
Biochemistry; 2013 Jun; 52(23):4003-13. PubMed ID: 23675771
[TBL] [Abstract][Full Text] [Related]
29. Expression and characterization of cyanobacterium heme oxygenase, a key enzyme in the phycobilin synthesis. Properties of the heme complex of recombinant active enzyme.
Migita CT; Zhang X; Yoshida T
Eur J Biochem; 2003 Feb; 270(4):687-98. PubMed ID: 12581208
[TBL] [Abstract][Full Text] [Related]
30. An enzymatically active chimeric protein containing the hydrophilic form of NADPH-cytochrome P450 reductase fused to the membrane-binding domain of cytochrome b5.
Gilep AA; Guryev OL; Usanov SA; Estabrook RW
Biochem Biophys Res Commun; 2001 Jun; 284(4):937-41. PubMed ID: 11409883
[TBL] [Abstract][Full Text] [Related]
31. Backbone assignments of the apo and Zn(II) protoporphyrin IX-bound states of the soluble form of rat heme oxygenase-1.
Harada E; Sugishima M; Harada J; Noguchi M; Fukuyama K; Sugase K
Biomol NMR Assign; 2015 Apr; 9(1):197-200. PubMed ID: 25209143
[TBL] [Abstract][Full Text] [Related]
32. Global effects of the energetics of coenzyme binding: NADPH controls the protein interaction properties of human cytochrome P450 reductase.
Grunau A; Paine MJ; Ladbury JE; Gutierrez A
Biochemistry; 2006 Feb; 45(5):1421-34. PubMed ID: 16445284
[TBL] [Abstract][Full Text] [Related]
33. The binding sites on human heme oxygenase-1 for cytochrome p450 reductase and biliverdin reductase.
Wang J; de Montellano PR
J Biol Chem; 2003 May; 278(22):20069-76. PubMed ID: 12626517
[TBL] [Abstract][Full Text] [Related]
34. Crystallization of recombinant human heme oxygenase-1.
Schuller DJ; Wilks A; Ortiz de Montellano P; Poulos TL
Protein Sci; 1998 Aug; 7(8):1836-8. PubMed ID: 10082382
[TBL] [Abstract][Full Text] [Related]
35. Functional reconstitution of monomeric CYP3A4 with multiple cytochrome P450 reductase molecules in Nanodiscs.
Grinkova YV; Denisov IG; Sligar SG
Biochem Biophys Res Commun; 2010 Jul; 398(2):194-8. PubMed ID: 20599740
[TBL] [Abstract][Full Text] [Related]
36. Dynamic and structural differences between heme oxygenase-1 and -2 are due to differences in their C-terminal regions.
Kochert BA; Fleischhacker AS; Wales TE; Becker DF; Engen JR; Ragsdale SW
J Biol Chem; 2019 May; 294(20):8259-8272. PubMed ID: 30944174
[TBL] [Abstract][Full Text] [Related]
37. Kinetic and structural characterization of the interaction between the FMN binding domain of cytochrome P450 reductase and cytochrome c.
Huang R; Zhang M; Rwere F; Waskell L; Ramamoorthy A
J Biol Chem; 2015 Feb; 290(8):4843-4855. PubMed ID: 25512382
[TBL] [Abstract][Full Text] [Related]
38. A role for highly conserved carboxylate, aspartate-140, in oxygen activation and heme degradation by heme oxygenase-1.
Fujii H; Zhang X; Tomita T; Ikeda-Saito M; Yoshida T
J Am Chem Soc; 2001 Jul; 123(27):6475-84. PubMed ID: 11439033
[TBL] [Abstract][Full Text] [Related]
39. Catalytic turnover dependent modification of the Pseudomonas aeruginosa heme oxygenase (pa-HO) by 5,6-O-isopropyledine-2-O-allyl-ascorbic acid.
Bhakta MN; Olabisi A; Wimalasena K; Wilks A
J Inorg Biochem; 2008 Feb; 102(2):251-9. PubMed ID: 17923157
[TBL] [Abstract][Full Text] [Related]
40. Alteration of the regiospecificity of human heme oxygenase-1 by unseating of the heme but not disruption of the distal hydrogen bonding network.
Wang J; Evans JP; Ogura H; La Mar GN; Ortiz de Montellano PR
Biochemistry; 2006 Jan; 45(1):61-73. PubMed ID: 16388581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
